7Baggers
 why replimune stock was soaring today  AOL.com Mon, 10 Nov 2025 17:20:20 GMT
 replimune reports positive data for melanoma treatment at sitc 2025  Investing.com Fri, 07 Nov 2025 08:00:00 GMT
 replimune group reports increased losses amid r&d expansion  TipRanks Fri, 07 Nov 2025 05:55:45 GMT
 replimune (repl) gains momentum with fda's acceptance of bla res  GuruFocus Thu, 06 Nov 2025 13:44:24 GMT
 Replimune Group Reports Increased Losses Amid R&D Expansion  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 replimune group (repl) to release earnings on tuesday  MarketBeat Wed, 05 Nov 2025 17:02:31 GMT
 BMO Capital Upgrades Replimune Group (REPL)  Nasdaq Mon, 03 Nov 2025 08:00:00 GMT
 Replimune stock rating upgraded by BMO Capital on improved FDA outlook  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 brokers set expectations for replimune group q2 earnings  MarketBeat Thu, 30 Oct 2025 13:06:49 GMT
 hc wainwright forecasts replimune group q2 earnings  MarketBeat Wed, 29 Oct 2025 11:17:59 GMT
 published on: 2025-10-27 17:22:37  newser.com Mon, 27 Oct 2025 22:22:37 GMT
 opinion | the spin doctors at the fda  The Wall Street Journal Mon, 27 Oct 2025 21:46:00 GMT
 replimune’s innovative cancer therapy: a phase 1 study update  TipRanks Mon, 27 Oct 2025 20:27:46 GMT
 hc wainwright & co. upgrades replimune group (repl)  Nasdaq Mon, 27 Oct 2025 12:03:00 GMT
 replimune upgraded to buy from neutral at h.c. wainwright  TipRanks Mon, 27 Oct 2025 10:36:14 GMT
 replimune group (nasdaq:repl) upgraded to buy at hc wainwright  MarketBeat Mon, 27 Oct 2025 07:00:00 GMT

Replimune Group, Inc
(NASDAQ:REPL) 

REPL stock logo

Replimune Group, Inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a...

Founded: 2015
Full Time Employees: 122
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends